Amitabha Mazumder

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

Paul G. Richardson, Edie Weller, Sagar Lonial et al. · Blood · 2010 · 862 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

Sagar Lonial, Brendan M. Weiss, Saad Z. Usmani et al. · The Lancet · 2016 · 850 citations

Medicine, Oncology, Pharmacotherapy +14

Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor.

Michael T. Lotze, Elizabeth A. Grimm, Amitabha Mazumder et al. · PubMed · 1981 · 523 citations

Medicine, Immunology, Oncology +9

Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma

Sundar Jagannath, Brian G.M. Durie, Jeffrey L. Wolf et al. · British Journal of Haematology · 2005 · 399 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Bortezomib enhances dendritic cell (DC)–mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications

Radek Špíšek, Anna Charalambous, Amitabha Mazumder et al. · Blood · 2007 · 378 citations · Full text

Life Sciences, Immunology, Oncology +17